QI
BMY icon

Qtron Investments’s Bristol-Myers Squibb BMY Stock Holding History

Qtron Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
19,699
+15
+0.1% +$874 0.16% 150
2025
Q4 		$1.06M Buy
19,684
+4,002
+26% +$193K 0.14% 169
2025
Q3 		$707K Sell
15,682
-15,112
-49% -$706K 0.09% 263
2025
Q2 		$1.43M Hold
30,794
– – 0.18% 128
2025
Q1 		$1.88M Buy
30,794
+10,177
+49% +$593K 0.28% 70
2024
Q4 		$1.17M Buy
20,617
+2,033
+11% +$114K 0.16% 143
2024
Q3 		$962K Hold
18,584
– – 0.13% 216
2024
Q2 		$772K Sell
18,584
-12,668
-41% -$567K 0.11% 218
2024
Q1 		$1.69M Buy
31,252
+10,469
+50% +$533K 0.24% 89
2023
Q4 		$1.07M Buy
20,783
+7,484
+56% +$393K 0.17% 142
2023
Q3 		$772K Sell
13,299
-6,883
-34% -$422K 0.15% 195
2023
Q2 		$1.29M Sell
20,182
-5,149
-20% -$345K 0.24% 93
2023
Q1 		$1.76M Hold
25,331
– – 0.36% 62
2022
Q4 		$1.82M Buy
25,331
+7,842
+45% +$591K 0.38% 58
2022
Q3 		$1.24M Sell
17,489
-3,594
-17% -$261K 0.31% 74
2022
Q2 		$1.62M Hold
21,083
– – 0.36% 63
2022
Q1 		$1.54M Buy
+21,083
New +$1.42M 0.34% 64
2021
Q4 		– Sell
-4,100
Closed -$243K – 334
2021
Q3 		$243K Sell
4,100
-6,076
-60% -$400K 0.07% 268
2021
Q2 		$680K Sell
10,176
-5,302
-34% -$346K 0.17% 179
2021
Q1 		$977K Buy
15,478
+1,509
+11% +$93.9K 0.27% 87
2020
Q4 		$866K Hold
13,969
– – 0.23% 101
2020
Q3 		$842K Hold
13,969
– – 0.29% 72
2020
Q2 		$821K Sell
13,969
-8,648
-38% -$517K 0.33% 68
2020
Q1 		$1.26M Buy
22,617
+1,197
+6% +$73.2K 0.76% 20
2019
Q4 		$1.38M Buy
+21,420
New +$1.23M 0.79% 23
2019
Q1 		– Sell
-4,365
Closed -$227K – 198
2018
Q4 		$227K Buy
+4,365
New +$235K 0.17% 158

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qtron Investments's BMY Position: Q1 2026 in Review

Qtron Investments increased its Bristol-Myers Squibb (BMY) stake by 0.08% in Q1 2026, buying an estimated $874 and bringing the position to 19,699 shares worth $1.19M. The position accounts for 0.16% of the portfolio, ranked #150.

Qtron Investments first reported a position in BMY in Q4 2018 and has held it in 26 quarters since. The position peaked at $1.88M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Qtron Investments held 19,699 shares of Bristol-Myers Squibb worth $1.19M as of Q1 2026.
  • Qtron Investments bought 15 Bristol-Myers Squibb shares in Q1 2026, an estimated $874.
  • Bristol-Myers Squibb made up 0.16% of Qtron Investments's portfolio in Q1 2026, its #150 holding.
  • Qtron Investments first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 26 quarters since.
  • Qtron Investments's Bristol-Myers Squibb position peaked at $1.88M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Qtron Investments's 13F filing for Q1 2026, filed 15 May 2026.